Skip to main content
Premium Trial:

Request an Annual Quote

Singing Away With an Extra Chromosome

Songbirds harbor an extra chromosome within their germline cells that aren't present in their other cells, New Scientist reports.

It adds that this phenomenon was first noticed in zebra finches in the late 1990s and now researchers from the Institute of Cytology and Genetics in Russia have found this pattern among other songbirds as well. As they report in the Proceedings of the National Academy of Sciences this week, the Russian team used antibodies to the synaptonemal complex of meiotic chromosomes to find that all 14 of the songbirds they investigated had this extra chromosome, while the eight other non-songbirds studied did not. The researchers note that that the size of the added chromosome varied from species to species, and they hypothesize that extra germline chromosome could be the result of a whole chromosome duplication in the ancestral songbird genome that underwent changes in its descendants.

New Scientist adds that this extra chromosome could provide an advantage and account for why songbirds make up about half of the 10,000 or so known bird species.


The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.